From: PD-L1/PD-1 crosstalk in colorectal cancer: are we targeting the right cells?
Characteristic | Value | % |
---|---|---|
All patients (n = 15) | ||
Age, years | 73.80 ± 7.79 | |
Sex | ||
Male | 10 | 66.7 |
Female | 5 | 33.3 |
Tumour location | ||
Caecum | 4 | 26.7 |
Ascending colon | 8 | 53.3 |
Transverse colon | 3 | 20 |
Emergency surgery | ||
Yes | 2 | 13.3 |
No | 13 | 86.7 |
Surgical procedure | ||
Laparoscopic right haemicolectomy | 13 | 86.7 |
Open right haemicolectomy | 2 | 13.3 |
TNMa stage | ||
I | 1 | 6.7 |
IIA | 6 | 40 |
IIB | 3 | 20 |
IIIA | 0 | 0 |
IIIB | 2 | 13.3 |
IIIC | 1 | 6.7 |
IVA | 2 | 13.3 |
IVB | 0 | 0 |
Adjuvant chemotherapy | ||
Yes | 6 | 40 |
No | 9 | 60 |
Hepatic metastases | ||
No | 12 | 80 |
Synchronous metastases | 2 | 13.3 |
Metachronous metastases | 1 | 6.7 |
MMR status | ||
pMMR | 13 | 86.6 |
dMMR | 1 | 6.7 |
Unknown | 1 | 6.7 |